A detailed history of Lord, Abbett & Co. LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 1,600,523 shares of ABT stock, worth $182 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
1,600,523
Previous 1,982,628 19.27%
Holding current value
$182 Million
Previous $225 Million 26.2%
% of portfolio
0.56%
Previous 0.74%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$100.73 - $112.44 $38.5 Million - $43 Million
-382,105 Reduced 19.27%
1,600,523 $166 Million
Q1 2024

May 09, 2024

BUY
$109.52 - $120.96 $42.4 Million - $46.9 Million
387,505 Added 24.29%
1,982,628 $225 Million
Q4 2023

Feb 12, 2024

BUY
$90.19 - $110.4 $2.35 Million - $2.88 Million
26,088 Added 1.66%
1,595,123 $176 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $12.7 Million - $15.3 Million
-133,200 Reduced 7.83%
1,569,035 $152 Million
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $7.4 Million - $8.24 Million
-73,380 Reduced 4.13%
1,702,235 $186 Million
Q1 2023

May 12, 2023

BUY
$96.86 - $114.01 $31.9 Million - $37.6 Million
329,800 Added 22.81%
1,775,615 $180 Million
Q4 2022

Feb 10, 2023

BUY
$95.06 - $111.52 $4.74 Million - $5.56 Million
49,895 Added 3.57%
1,445,815 $159 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $1.98 Million - $2.3 Million
20,488 Added 1.49%
1,395,920 $135 Million
Q2 2022

Aug 12, 2022

SELL
$102.07 - $123.37 $40,828 - $49,348
-400 Reduced 0.03%
1,375,432 $149 Million
Q1 2022

May 13, 2022

SELL
$114.02 - $139.04 $50.5 Million - $61.6 Million
-442,995 Reduced 24.36%
1,375,832 $163 Million
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $83 Million - $102 Million
718,082 Added 65.24%
1,818,827 $256 Million
Q3 2021

Nov 09, 2021

BUY
$116.66 - $129.06 $65.4 Million - $72.4 Million
560,800 Added 103.86%
1,100,745 $130 Million
Q2 2021

Aug 11, 2021

SELL
$105.79 - $124.53 $55.5 Million - $65.4 Million
-524,816 Reduced 49.29%
539,945 $62.6 Million
Q1 2021

May 11, 2021

SELL
$108.84 - $128.23 $13.8 Million - $16.3 Million
-127,082 Reduced 10.66%
1,064,761 $128 Million
Q4 2020

Feb 09, 2021

BUY
$105.0 - $114.42 $2.71 Million - $2.96 Million
25,852 Added 2.22%
1,191,843 $130 Million
Q3 2020

Nov 12, 2020

SELL
$91.64 - $111.29 $4.22 Million - $5.12 Million
-46,006 Reduced 3.8%
1,165,991 $127 Million
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $27.2 Million - $34.8 Million
355,290 Added 41.47%
1,211,997 $111 Million
Q1 2020

May 14, 2020

SELL
$62.82 - $91.86 $2.18 Million - $3.19 Million
-34,700 Reduced 3.89%
856,707 $67.6 Million
Q4 2019

Feb 14, 2020

SELL
$78.51 - $87.4 $737,444 - $820,948
-9,393 Reduced 1.04%
891,407 $77.4 Million
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $14.1 Million - $15.3 Million
172,300 Added 23.65%
900,800 $75.4 Million
Q2 2019

Aug 14, 2019

SELL
$72.88 - $85.0 $54.5 Million - $63.6 Million
-747,823 Reduced 50.65%
728,500 $61.3 Million
Q1 2019

May 15, 2019

SELL
$66.22 - $80.06 $69.9 Million - $84.5 Million
-1,055,555 Reduced 41.69%
1,476,323 $118 Million
Q4 2018

Feb 14, 2019

SELL
$65.56 - $74.27 $59.9 Million - $67.9 Million
-913,918 Reduced 26.52%
2,531,878 $183 Million
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $70.6 Million - $85.1 Million
-1,160,394 Reduced 25.19%
3,445,796 $253 Million
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $21.3 Million - $23.6 Million
-370,784 Reduced 7.45%
4,606,190 $281 Million
Q1 2018

May 15, 2018

BUY
$56.27 - $63.62 $7.51 Million - $8.5 Million
133,545 Added 2.76%
4,976,974 $298 Million
Q4 2017

Feb 14, 2018

BUY
$53.68 - $57.47 $6.72 Million - $7.2 Million
125,265 Added 2.65%
4,843,429 $276 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $36.1 Million - $40.3 Million
751,446 Added 18.94%
4,718,164 $252 Million
Q2 2017

Aug 14, 2017

BUY
N/A
3,966,718
3,966,718 $193 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.